Abstract
OBJECTIVE
We assessed the frequency and relatedness of methicillin-resistant Staphylococcus aureus (MRSA) isolates to determine whether healthcare workers, the environment, or admitted patients could be a reservoir for MRSA on a burn trauma unit (BTU). We also assessed risk factors for MRSA colonization among BTU patients.
DESIGN
Prospective cohort study and surveillance for MRSA carriage.
SETTING
BTU of a Midwestern academic medical center.
PATIENTS AND PARTICIPANTS
Patients admitted to a BTU from February 2009 through January 2010 and healthcare workers on this unit during the same time period.
METHODS
Samples for MRSA culture were collected on admission from the nares and wounds of all BTU patients. We also had collected culture samples from the throat, axilla, antecubital fossa, groin, and perianal area of 12 patients per month. Samples collected from healthcare workers’ nares and from environmental sites were cultured quarterly. MRSA isolates were typed by pulsed-field gel electrophoresis.
RESULTS
Of 144 patients, 24 (17%) carried MRSA in their nares on admission. Male sex (odds ratio [OR], 5.51; 95% confidence interval [95% CI], 1.25–24.30), admission for necrotizing fasciitis (OR, 7.66; 95% CI, 1.64–35.81), and MRSA colonization of a site other than the nares (OR, 23.40; 95% CI, 6.93–79.01) were independent predictors of MRSA nasal carriage. Cultures of samples collected from 4 healthcare workers and 4 environmental cultures had positive results. Two patients were colonized with strains that were indistinguishable from strains collected from a healthcare worker or the environment.
CONCLUSIONS
Patients were a major reservoir for MRSA. Infection control efforts should focus on preventing transmission of MRSA from patients who are MRSA carriers to other patients on the unit.
Compared with other hospitalized patients, burn patients have a higher risk of acquiring infections caused by methicillin-resistant Staphylococcus aureus (MRSA) because they often stay in the hospital for prolonged periods, their skin is damaged, and their immunity is suppressed.1–4 Prior studies have found that 23%–45% of healthcare-associated infections in burn units are caused by S. aureus.5–9
To prevent MRSA infections in burn patients and to prioritize infection control efforts, we must determine the primary reservoirs and modes of transmission for this organism on a specific unit. Endogenous transmission, in which MRSA is transferred from one body site on a patient to another on the same patient (eg, from the nares to a wound), can be prevented by decolonizing patients with agents such as mupirocin.10–13 Exogenous transmission, in which MRSA is transferred from patient to patient or from the hospital environment to a patient, can be prevented by enhancing healthcare workers’ (HCWs’) hand hygiene, isolating colonized or infected patients, and enhancing environmental cleaning and disinfection.10–17
A previous study conducted in our burn trauma unit (BTU) found that many of the MRSA isolates collected from patients were related via molecular typing, suggesting a common source.18 Thus, this study aimed to determine whether HCWs on the BTU or the BTU’s environment could be a source of MRSA for patients admitted to this unit, so that we could determine which infection prevention and control measures might be most effective. Additionally, we aimed to identify risk factors for MRSA colonization so that we could identify patients who should be targeted for infection control efforts such as active surveillance and isolation.
methods
Setting
This prospective cohort study included patients who were admitted to the BTU of a teaching hospital with a level-1 trauma center. The BTU has 16 beds (2 double rooms, 12 single rooms) and admits a mean of 25 patients per month, including 15 burn patients. The BTU is a regional unit that serves the state of Iowa; the unit also serves as a step-down unit for general surgical and trauma patients. Throughout the study period, nurses on the BTU obtained nasal swab samples from patients at admission and weekly to identify those who were colonized with MRSA. Routine wound samples were obtained weekly from burn and wound patients. Contact precautions were taken with all patients admitted to the unit until negative results were obtained for initial screening tests. Contact precautions were retained for patients whose nares or wounds were colonized with MRSA.
We have conducted several studies on the epidemiology of MRSA on this BTU.7,13,18–20 The prevalence of MRSA on admission was approximately 5.1%, the overall prevalence of MRSA colonization or infection was estimated to range from 6.0% to 8.9%,13,19 and MRSA caused more than one-third of the bloodstream infections and burn wound infections in this unit.7 Care of burns in this unit has been described previously.20 In short, we excised full-thickness wounds early and applied either split-thickness autografts or cadaver skin. We then performed staged autografting of the cadaver-grafted areas. Dressings were changed in the hydrotherapy room.
Study Design
From February 2009 through January 2010, we obtained informed consent from and enrolled 12 randomly selected patients per month. Each study patient’s throat, axillae, antecubital fossae, groin, and perianal area were swabbed. In addition, BTU nurses collected the standard surveillance samples from each patient’s nares and wounds. However, for the purposes of this study, we were unable to distinguish between wound colonization and wound infection. We reviewed each patient’s medical record and abstracted information onto a standardized form that included data such as patient demographics, admitting diagnosis, medical history, devices present, and history of MRSA colonization or infection before study enrollment (Table 1).
TABLE 1.
Patient Demographics Stratified by the Results of the Admission Nares Screen
| Nares screen result for MRSA on admission |
||||
|---|---|---|---|---|
| Positivea (n = 24) |
Negative (n = 119) |
All participants (n = 144) |
P | |
| Male sex | 21 (87.5) | 74 (62.2) | 95 (66.0) | .02 |
| Age, median years (IQR) | 59 (52–62) | 53 (38–64) | 54 (39–63) | NS |
| Place of residence | NS | |||
| Home | 21 (87.5) | 113 (95.0) | 135 (93.7) | |
| Skilled nursing facility | 3 (12.5) | 3 (2.5) | 6 (4.2) | |
| Nursing home | 0 (0) | 1 (0.8) | 1 (0.7) | |
| Homeless | 0 (0) | 2 (1.7) | 2 (1.4) | |
| Admitting diagnosis | .002 | |||
| Burn | 4 (16.7) | 27 (22.7) | 31 (21.5) | |
| Necrotizing fasciitis | 6 (25.0) | 6 (5.0) | 12 (8.3) | |
| Trauma | 1 (4.2) | 37 (31.1) | 38 (26.4) | |
| Wound care | 6 (25.0) | 30 (25.2) | 37 (25.7) | |
| Otherb | 7 (29.2) | 19 (16.0) | 26 (18.1) | |
| Medical history before study enrollment | ||||
| Prior receipt of antimicrobial agents | 21 (87.5) | 81 (68.9) | 104 (72.2) | .06 |
| Prior surgery | 18 (75.0) | 75 (63.0) | 94 (65.3) | NS |
| Devices present before study enrollment | ||||
| Foley catheter | 19 (79.2) | 76 (63.9) | 96 (66.7) | NS |
| Central venous catheter | 9 (37.5) | 31 (26.1) | 41 (28.5) | NS |
| Enteral feeding tube | 6 (25.0) | 14 (11.8) | 20 (13.9) | NS |
| Ventilator | 9 (37.5) | 30 (25.2) | 39 (27.1) | NS |
| History of MRSA colonization or infection before study enrollment | 24 (100) | 4 (3.4) | 29 (20.1) | <.01 |
NOTE. Data are no. (%) of admissions, unless otherwise indicated. IQR, interquartile range; MRSA, methicillin-resistant Staphylococcus aureus; NS, not significant.
One nares screen was not performed.
Including postoperative admission, soft tissue infection, abdominal issue (eg, pancreatitis), skin issue (eg, erythroderma), overflow, cancer, inhalation injury, and gallstones.
Research assistants swabbed HCWs’ nares and potential fomites in the patient environment quarterly. Potential fomites were located in patient rooms (eg, bed trays, supply cabinets, and bed rails) and shared areas (eg, tubs, hoses, shower heads, tub handles, sinks, computers, phones, playroom toys, door handles, door plates, refrigerator, microwave, therapy gym equipment, physical therapy room equipment, and soap dispensers). The University of Iowa’s Institutional Review Board approved this study.
Microbiologic and Molecular Typing Methods
Nurses on the BTU rubbed premoistened swabs in patients’ nares to obtain samples to perform admission MRSA surveillance cultures. Samples were inoculated into 2 mL of brain-heart-infusion broth. After 24 h of incubation at 35 °C, a 1 : 100 dilution was made and inoculated onto selective MRSA agar plates (BBL CHROMagar MRSA, Becton Dickinson). These plates were incubated for 24–48 hours at 35 °C and then examined for MRSA.21 Isolates were confirmed to be S. aureus when their appearance was observed with Gram staining and following positive results of the catalase test, the S. aureus latex agglutination assay (Pastorex Staph-plus, BioRad), and the tube coagulase test, as required. Admission and weekly wound cultures were processed by staff in the Clinical Microbiology Laboratory, using standard microbiological methods.
Upon a patient’s enrollment into the study, research assistants rubbed premoistened swabs in the patient’s throat, axillae, antecubital fossae, groin, and perianal area to obtain samples for MRSA culturing. Research assistants also used premoistened swabs to collect environmental samples. All patient and environmental samples were processed as outlined above. Laboratory personnel used the Clinical and Laboratory Standards Institute broth microdilution method to perform antimicrobial susceptibility testing on all MRSA isolates.22 Low-level mupirocin resistance was defined as a minimum inhibitory concentration (MIC) of 8–256 µg/mL, and high-level mupirocin resistance was defined as an MIC greater than 512 µg/mL.22 We performed pulsed-field gel electrophoresis (PFGE) on all MRSA isolates that had been collected for research purposes,23 and we used the BioNumerics software to compare the PFGE patterns with those of the Centers for Disease Control and Prevention’s USA-type strains.24 A similarity coefficient of 75% was used to determine PFGE subtypes.
Statistical Analysis
We assessed bivariable associations using the χ2 test or the Fisher exact test for categorical variables and the Student t test or the Wilcoxon rank-sum test for continuous variables. We used logistic regression analysis to identify independent risk factors for MRSA colonization. We included all variables that were significant in the bivariable analyses (α < 0.1) in the initial model and then removed in succession those variables that were not significantly associated with MRSA-positive surveillance cultures (α < 0.05). We created contingency tables to calculate the sensitivity, specificity, positive predictive value, and negative predictive value of nasal surveillance cultures to predict MRSA colonization at other body sites. We used SAS software (SAS Institute), version 9.1, for all analyses.
Results
During the entire study period, 595 patients were admitted to the BTU. Approximately 7% carried MRSA in their nares on admission, 2% acquired nasal colonization during their BTU admission, and for 8%, a clinical culture had positive results for MRSA during the BTU admission.
Twelve individual patients per month were enrolled in this study, for a total of 144 patients. The median age of the study patients was 54 years (IQR, 39–63), and 66% of the patients were male. Twenty percent of the study patients had a history of MRSA colonization or infection before they were admitted to the BTU. Most study patients resided in their own homes (93.7%; Table 1). The most common reasons for admission to the BTU were trauma (26.4%), wound care (25.7%), burn (21.5%), and necrotizing fasciitis (8.3%). MRSA was isolated from 3 patients who had necrotizing fasciitis; from 1 of these, group G Streptococcus was also isolated. Other organisms causing necrotizing fasciitis were as follows: methicillin-susceptible S. aureus and group B Streptococcus (n = 1), group G Streptococcus and Prevotella spp. (n = 1), group G Streptococcus (n = 1), and vancomycin-susceptible Enterococcus (n = 1). Three patients had negative culture results while at the University of Iowa Hospitals and Clinics but had received antimicrobial agents at other hospitals, which may have affected these results.
MRSA Surveillance among Patients
Seventeen percent (24/144) of the study patients carried MRSA in their nares on admission. Male sex, a prior history of MRSA colonization or infection, and an admitting diagnosis of necrotizing fasciitis were significantly associated with MRSA nasal carriage on admission (Table 1). Conversely, patients admitted to the BTU for trauma were significantly less likely than other patients to be carrying MRSA in their nares when they were admitted (Table 1). A higher percentage of the patients who carried MRSA in their nares on admission to the BTU had received treatment with antimicrobial agents in the period between hospital admission and admission to the BTU, but the difference is not statistically significant. Age, place of residence, surgery in the period between hospital admission and BTU admission, and the presence of a central venous catheter, Foley catheter, or enteral feeding tube before enrollment or at the time of enrollment were not associated with MRSA carriage in the nares at admission (Table 1).
Of the 36 patients who had MRSA colonization at any body site, 25.7% were colonized in the nares only, 31.4% were colonized at a body site other than the nares, and 42.8% were colonized in both the nares and another body site. The most common extranasal carriage sites were wounds (n = 12), the throat (n = 9), and the perianal area (n = 9). Eleven (9.2%) of the 120 patients who did not have MRSA carriage in the nares had MRSA colonization at another site. The body sites where we found MRSA colonization are listed in Table 2.
TABLE 2.
Number of Body Sites Testing Positive for Methicillin-Resistant Staphylococcus aureus
| Body site | No. of patients (N = 144) |
|---|---|
| Five body sites (%) | 1 (0.7) |
| Groin, perianal area, throat, wound, nares | 1 |
| Four body sites (%) | 4 (2.8) |
| Perianal area, throat, wound, nares | 3 |
| Groin, perianal area, throat, nares | 1 |
| Three body sites (%) | 5 (3.5) |
| Groin, perianal area, wound | 1 |
| Perianal area, throat nares | 1 |
| Throat, wound, nares | 1 |
| Axilla, wound, nares | 1 |
| Antecubital fossae, wound, nares | 1 |
| Two body sites (%) | 7 (4.9) |
| Wound, nares | 4 |
| Perianal area, wound | 1 |
| Perianal area, nares | 1 |
| Groin, nares | 1 |
| One body site (%) | 19 (13.2) |
| Nares | 9 |
| Wound | 8 |
| Throat | 2a |
| No body sites (%) | 108 (75.0) |
A nares sample culture was not performed for 1 patient.
The sensitivity of cultures of nasal swabs at admission to be able to predict MRSA colonization at other body sites was only moderate (sensitivity, 57.7%), because nasal carriage on admission identified only 52.3% of the patients who had MRSA in their wounds (colonization or infection). In contrast, 78.6% of the patients who had MRSA-positive cultures of samples collected from body sites other than wounds were also found to be carrying MRSA in their nares. The combined sensitivity of nares and wound screens (ie, if one or the other is positive) to predict a positive culture result for another body site was 92.9% (Table 3).
TABLE 3.
Sensitivity, Specificity, and Predictive Values of Admission Screening and Methicillin-Resistant Staphylococcus aureus–Positive Cultures of Samples Collected from Other Sites
| Sensitivity | Specificity | PPV | NPV | |
|---|---|---|---|---|
| Association between admission nares screening results and | ||||
| Wound colonization or infection | 52.3 | 89.4 | 45.8 | 91.6 |
| Throat colonization | 87.5 | 87.4 | 29.1 | 99.1 |
| Groin colonization | 75.0 | 84.9 | 12.5 | 99.2 |
| Perianal area colonization | 77.8 | 87.3 | 29.2 | 98.3 |
| Antecubital fossae colonization | 100 | 83.8 | 4.2 | 100 |
| Axilla colonization | 100 | 83.8 | 4.2 | 100 |
| Any nonnasal colonization | 57.7 | 92.3 | 62.5 | 90.8 |
| Any nonnasal, nonwound colonization | 78.6 | 89.9 | 45.8 | 97.5 |
| Association between nares or wound screening results and colonization at other site | 92.9 | 85.3 | 40.6 | 99.1 |
NOTE. Data are percentages. NPV, negative predictive value; PPV, positive predictive value.
Three factors were independently associated with MRSA nasal carriage on admission: male sex (adjusted OR, 5.51; 95% CI, 1.25–24.30), necrotizing fasciitis as the reason for admission (adjusted OR, 7.66; 95% CI, 1.64–35.81), and cultures that grew MRSA of samples obtained from a body site other than the nares (adjusted OR, 23.40; 95% CI, 6.93–79.01). Risk factors independently associated with MRSA at a body site other than the nares included a prior history of MRSA colonization or infection (adjusted OR, 43.64; 95% CI, 12.70–150.00) and wound care as the reason for admission (adjusted OR, 4.90; 95% CI, 1.36–17.52).
HCW Colonization with MRSA and Environmental Contamination with MRSA
The nares of 67 unique HCWs on the BTU were swabbed for culturing (n = 238 samples). Four HCWs were colonized with MRSA at least once during the study period. Eighty percent (54/67) of HCWs, including the 4 carriers, were screened during all 4 quarters of the study period. One HCW was colonized for 3 quarters, 1 was colonized for 2 quarters, and 2 were colonized for 1 quarter. Colonized HCWs were treated with nasal mupirocin.
Fifty environmental samples were collected during the first quarter, 33 during the second quarter, 21 during the third quarter, and 32 during the fourth quarter, for a total of 136 cultures. None of the environmental samples obtained during quarters 1, 3, and 4 grew MRSA. During quarter 2, a total of 4 samples (2.9% of all samples, 12.1% of samples from quarter 2) grew MRSA. Samples obtained from the handles on the inside and the outside of the door to the physical therapy room, the bed mat in the physical therapy room, and a bed rail inside a patient’s room grew MRSA.
Microbiologic and Molecular Results
Figure 1 includes PFGE patterns from patient isolates (axillae, antecubital fossae, groin, and perianal area), HCWs, and the environment. Most isolates from patients, all isolates from staff, and all isolates from the environment were USA100. Two patients were colonized with USA300, 1 patient was colonized with USA400, and 1 patient was colonized with USA700. Three of 4 environmental isolates had the same PFGE subtype. Staff members who were colonized at more than 1 time point were colonized by the same strain each time. Similarly, patients who carried MRSA at more than 1 body site carried the same strain at each body site. In 2 cases, isolates obtained from patients were indistinguishable from those obtained from HCWs or environmental strains. A USA100 subtype was shared by 3 patients and 1 HCW. One environmental isolate and 1 patient isolate were of the same USA100 subtype. In these cases, the patient was found to be colonized before either the HCWs or the environment were found to be colonized or contaminated.
Figure 1.
Dendrogram of methicillin-resistant Staphylococcus aureus (MRSA) isolates collected from patients, the environment, and healthcare workers.
Most MRSA isolates (91%) were resistant to erythromycin. Isolates from 6 patients and 1 HCW were resistant to clindamycin and erythromycin. All isolates were susceptible to linezolid, daptomycin, quinupristin-dalfopristin, rifampin, trimethoprim-sulfamethoxazole, gentamicin, and vancomycin. Two patients were colonized with a MRSA isolate that had low-level mupirocin resistance. All 3 MRSA isolates from HCW 1 had low-level mupirocin resistance, and both MRSA isolates from HCW 3 were highly resistant to mupirocin. HCW 1 did not have prior exposure to mupirocin before this study, whereas HCW 3 had received nasal mupirocin before employment on the BTU.
DISCUSSION
In this prospective cohort study performed on a BTU, we sought to assess the primary reservoir for MRSA. We found that HCWs and the environment were not major reservoirs for MRSA transmission. Rather, patients who had been admitted to the unit for reasons other than burns or trauma and who were carrying MRSA in their nares on admission were the primary MRSA reservoir. Moreover, all patients who carried MRSA in their nares on admission had prior histories of MRSA colonization or infection.
These results are consistent with the findings of a prior cross-sectional study25 in which we obtained cultures from 112 HCWs on the BTU and found only 3 MRSA carriers (2.7%). Similarly, Dansby et al26 obtained cultures from HCWs and the environment on their burn unit and found that all of the cultures of environmental samples had negative results and only 2.3% of the cultures of samples obtained from HCWs were positive for MRSA. In contrast to the findings in our study, a recent cross-sectional study conducted by Andrade et al2 found that 30% of the environmental surfaces in a burn unit were contaminated with MRSA; however, the sites of contamination (eg, bed rails) in that study were similar to those in our study. In our study, only 4 cultures of environmental samples had MRSA-positive results, even though cultures were collected from high-risk environmental sites such as shared tub rooms. Thus, the environment probably does not play a large role in MRSA transmission in our BTU. The difference between our results and those of Andrade et al may be the result of variations in cleaning among the hospitals. Carling et al27 found that among 27 intensive care units, thoroughness of cleaning varied substantially and did not correlate with hospital size, patient volume, case mix index, geographic location, or teaching status.
In this study, admission to the BTU for necrotizing fasciitis was independently associated with MRSA colonization of the nares on admission, and admission to the BTU for wound care was independently associated with MRSA colonization at body sites other than the nares. Similarly, a prior case-control study found that admission to our BTU for burns or for trauma was associated with a lower risk of MRSA colonization or infection than were other reasons for admission, including necrotizing fasciitis and wound care.13 Moreover, a study from the Netherlands found that two-thirds of patients whose burn wounds were colonized with methicillin-susceptible S. aureus had acquired the organism exogenously.28 Thus, infection control efforts in BTUs should focus on preventing transmission of MRSA from patient to patient, particularly from patients admitted for reasons other than burns or trauma. Potential infection prevention and control efforts could include conducting targeted active surveillance for MRSA, isolating patients who are carrying MRSA, decolonizing carriers, or placing patients who have admitting diagnoses other than burns or trauma on different units. Given that patients who were colonized at more than 1 body site were always colonized with a single MRSA strain, decolonization or decontamination efforts could help to prevent endogenous transmission.
Other studies have demonstrated that the sensitivity of nares sample cultures to detect MRSA colonization varies substantially, with rates ranging from 69% to 91%. Several investigators have found that sensitivity improved substantially when samples were obtained from other body sites.29,30 In our study, the sensitivity of nares sample cultures to detect MRSA colonization at other body sites was low, primarily because these results did not predict wound colonization or infection. Screening both the nares and wounds would have missed only 1 patient who had MRSA carriage. Thus, the BTU’s current policy of screening the nares and wounds on admission and screening wounds weekly has a high sensitivity for finding patients in our patient population who are colonized with MRSA.
Our study has some limitations. We evaluated a BTU in a single center that cares for a heterogeneous patient population. Thus, our results may not be generalizable to burn units that have different patient populations, such as units that admit only patients who have burns. Also, we were unable to type the isolates obtained from the nares of MRSA-colonized patients because those samples were evaluated by the clinical laboratory, not the research laboratory. However, we previously reported that 90% of the BTU patients who had S. aureus carriage in their nares and who were colonized or infected with S. aureus at another site had the same strain at each site.31
Future studies should assess other causes of MRSA transmission on burn units, such as MRSA aerosolization during dressing changes.26 Future studies should also frequently sample patients, HCWs, and the environment to determine whether MRSA is transferred from HCWs or the environment to patients or from patients to HCWs or the environment.
In conclusion, we found that patients, not HCWs or the environment, were the most likely primary reservoir for MRSA in our BTU. Patients admitted to the BTU for reasons other than burns or trauma and patients who had a prior history of MRSA colonization or infection were the most likely to be colonized with MRSA. HCWs should use best infection prevention practices when caring for these patients, to prevent transferring the organism from one body site to another in colonized patients and to ensure that MRSA is not transmitted to highly susceptible patients with burns.
ACKNOWLEDGMENTS
Financial support. This study was funded by the Centers for Disease Control and Prevention’s Epicenter program (5R18CI000583). M.S. was supported by a University of Iowa Clinical and Translational Science Award (NIH/NCRR-3KL2 RR024980-04S1).
Footnotes
Potential conflicts of interest. All authors report no potential conflicts of interest relevant to this article. All authors submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest, and the conflicts that the editors consider relevant to this article are disclosed here.
Presented in part: Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; Dallas, Texas; April 1–4, 2011.
References
- 1.Barlow Y. T lymphocytes and immunosuppression in the burned patient: a review. Burns. 1994;20(6):487–490. doi: 10.1016/0305-4179(94)90002-7. [DOI] [PubMed] [Google Scholar]
- 2.Andrade C, Champagne S, Caruso D, Foster K, Reynolds K. Methicillin-resistant Staphylococcus aureus : an assessment of environmental contamination in a burn center. Am J Infect Control. 2009;37(6):515–517. doi: 10.1016/j.ajic.2008.10.026. [DOI] [PubMed] [Google Scholar]
- 3.Cook N. Methicillin-resistant Staphylococcus aureus versus the burn patient. Burns. 1998;24(2):91–98. doi: 10.1016/s0305-4179(97)00114-9. [DOI] [PubMed] [Google Scholar]
- 4.Boyce JM, White RL, Causey WA, Lockwood WR. Burn units as a source of methicillin-resistant Staphylococcus aureus infections. JAMA. 1983;249(20):2803–2807. [PubMed] [Google Scholar]
- 5.Taylor GD, Kibsey P, Kirkland T, Burroughs E, Tredget E. Pre-dominance of staphylococcal organisms in infections occurring in a burns intensive care unit. Burns. 1992;(4):332–335. doi: 10.1016/0305-4179(92)90158-q. [DOI] [PubMed] [Google Scholar]
- 6.Appelgren P, Bjornhagen V, Bragderyd K, Jonsson CE, Ransjo U. A prospective study of infections in burn patients. Burns. 2002;(1):39–46. doi: 10.1016/s0305-4179(01)00070-5. [DOI] [PubMed] [Google Scholar]
- 7.Wibbenmeyer L, Williams I, Ward M, et al. Risk factors for acquiring vancomycin-resistant Enterococcus and methicillin-resistant Staphylococcus aureus on a burn surgery step-down unit. J Burn Care Res. 2010;31(2):269–279. doi: 10.1097/BCR.0b013e3181d0f479. [DOI] [PubMed] [Google Scholar]
- 8.Ressner RA, Murray CK, Griffith ME, Rasnake MS, Hospenthal DR, Wolf SE. Outcomes of bacteremia in burn patients involved in combat operations overseas. J Am Coll Surg. 2008;206(3):439–444. doi: 10.1016/j.jamcollsurg.2007.09.017. [DOI] [PubMed] [Google Scholar]
- 9.Mayhall CG. The epidemiology of burn wound infections: then and now. Clin Infect Dis. 2003;37(4):543–550. doi: 10.1086/376993. [DOI] [PubMed] [Google Scholar]
- 10.Kooistra-Smid M, Nieuwenhuis M, van Belkum A, Verbrugh H. The role of nasal carriage in Staphylococcus aureus burn wound colonization. FEMS Immunol Med Microbiol. 2009;57(1):1–13. doi: 10.1111/j.1574-695X.2009.00565.x. [DOI] [PubMed] [Google Scholar]
- 11.Kooistra-Smid AM, van Zanten E, Ott A, et al. Prevention of Staphylococcus aureus burn wound colonization by nasal mupirocin. Burns. 2008;34(6):835–839. doi: 10.1016/j.burns.2007.09.011. [DOI] [PubMed] [Google Scholar]
- 12.Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol. 2003;24(5):362–386. doi: 10.1086/502213. [DOI] [PubMed] [Google Scholar]
- 13.Wibbenmeyer L, Appelgate D, Williams I, et al. Effectiveness of universal screening for vancomycin-resistant Enterococcus and methicillin-resistant Staphylococcus aureus on admission to a burn-trauma step-down unit. J Burn Care Res. 2009;(4):648–656. doi: 10.1097/BCR.0b013e3181abff7e. [DOI] [PubMed] [Google Scholar]
- 14.Dancer SJ. Importance of the environment in methicillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis. 2008;8(2):101–113. doi: 10.1016/S1473-3099(07)70241-4. [DOI] [PubMed] [Google Scholar]
- 15.Datta R, Platt R, Yokoe DS, Huang SS. Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants. Arch Intern Med. 2011;171(6):491–494. doi: 10.1001/archinternmed.2011.64. [DOI] [PubMed] [Google Scholar]
- 16.Kaiser ML, Thompson DJ, Malinoski D, Lane C, Cinat ME. Epidemiology and risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus among burn patients. J Burn Care Res. 2011;32(3):429–434. doi: 10.1097/BCR.0b013e318217f92d. [DOI] [PubMed] [Google Scholar]
- 17.Siegel JD, Rhinehart E, Jackson M, Chiarello L. Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165–S193. doi: 10.1016/j.ajic.2007.10.006. [DOI] [PubMed] [Google Scholar]
- 18.Sigurdardottir B, Berg JV, Hu J, et al. Descriptive epidemiology and case-control study of patients colonized with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2006;27(9):913–919. doi: 10.1086/507278. [DOI] [PubMed] [Google Scholar]
- 19.Huang SS, Rifas-Shiman SL, Warren DK, et al. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis. 2007;195(3):330–338. doi: 10.1086/510622. [DOI] [PubMed] [Google Scholar]
- 20.Wibbenmeyer L, Danks R, Faucher L, et al. Prospective analysis of nosocomial infection rates, antibiotic use, patterns of resistance in a burn population. J Burn Care Res. 2006;27(2):152–160. doi: 10.1097/01.BCR.0000203359.32756.F7. [DOI] [PubMed] [Google Scholar]
- 21.Flayhart D, Hindler JF, Bruckner DA, et al. Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. J Clin Microbiol. 2005;43(11):5536–5540. doi: 10.1128/JCM.43.11.5536-5540.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing—Nineteenth Informational Supplement. Wayne, PA: CLSI; 2008. CLSI document M100-S19. [Google Scholar]
- 23.Pfaller MA, Hollis RJ, Sader HS. Chromosomal restriction fragment analysis by pulsed-field gel electrophoresis. In: Isenberg HD, editor. Clinical Microbiology Procedures Handbook. Washington, DC: American Society for Microbiology; 1994. pp. 10.5.c.1–10.5.c.12. [Google Scholar]
- 24.McDougal LK, Steward CD, Killgore GE, Chaitram JM, Mc-Allister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41(11):5113–5120. doi: 10.1128/JCM.41.11.5113-5120.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Wibbenmeyer LA, Kealey GP, Latenser BA, et al. Emergence of the USA300 strain of methicillin-resistant Staphylococcus aureus in a burn-trauma unit. J Burn Care Res. 2008;29(5):790–797. doi: 10.1097/BCR.0b013e3181848b8f. [DOI] [PubMed] [Google Scholar]
- 26.Dansby W, Purdue G, Hunt J, et al. Aerosolization of methicillin-resistant Staphylococcus aureus during an epidemic in a burn intensive care unit. J Burn Care Res. 2008;29(2):331–337. doi: 10.1097/BCR.0b013e3181667583. [DOI] [PubMed] [Google Scholar]
- 27.Carling PC, Parry MF, Bruno-Murtha LA, Dick B. Improving environmental hygiene in 27 intensive care units to decrease multidrug-resistant bacterial transmission. Crit Care Med. 2010;38(4):1054–1059. doi: 10.1097/CCM.0b013e3181cdf705. [DOI] [PubMed] [Google Scholar]
- 28.Kooistra-Smid M, van Dijk S, Beerthuizen G, et al. Molecular epidemiology of Staphylococcus aureus colonization in a burn center. Burns. 2004;30(1):27–33. doi: 10.1016/j.burns.2003.09.014. [DOI] [PubMed] [Google Scholar]
- 29.Mermel LA, Cartony JM, Covington P, Maxey G, Morse D. Methicillin-resistant Staphylococcus aureus colonization at different body sites: a prospective, quantitative analysis. J Clin Microbiol. 2011;49(3):1119–1121. doi: 10.1128/JCM.02601-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Marshall C, Spelman D. Re: is throat screening necessary to detect methicillin-resistant Staphylococcus aureus colonization in patients upon admission to an intensive care unit? J Clin Microbiol. 2007;45(11):3855. doi: 10.1128/JCM.01176-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Reighard A, Diekema D, Wibbenmeyer L, Ward M, Herwaldt L. Staphylococcus aureus nasal colonization and colonization or infection at other body sites in patients on a burn trauma unit. Infect Control Hosp Epidemiol. 2009;30(8):721–726. doi: 10.1086/598681. [DOI] [PubMed] [Google Scholar]

